Glenmark Pharma’s Goa branch receives a warning from USFDA

The company added that it intends to collaborate closely with the USFDA and is dedicated to resolving the matter within the allotted period.

Sruthi Subramanian

This post is for paying subscribers only

SUBSCRIBE NOW

Already have an account? Login